Tags: Drug.

Atazanavir (pronunciation: /ˌæ.tə.ˈzæ.nə.vɪər/ A-tə-ZA-nə-vir) marketed under the trade name Reyataz by Bristol Myers (formerly known as BMS-232632) is an antiretroviral drug of the protease inhibitor (PI) class.

Atazanavir-skeletal.svg
ATC prefix
J05
ATC suffix
AE08
Bioavailability
60.0
CAS number
198904-31-3
ChEBI
37924
DrugBank
DB01072
FDA UNII code
QZU4H47A3S
IUPAC name
methyl N-[(1S)-1-[(2S3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-33-dimethyl-N'-[4-(pyridin-2-yl)phenyl]methylbutanehydrazido]-1-phenylbutan-2-yl]carbamoyl-22-dimethylpropyl]carbamate
PubChem
148192

Loading...

This page contains content from the copyrighted Wikipedia article "Atazanavir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.